Pancreatic Cancer

What We Learned About Treatment Options

When my father was diagnosed, I thought what I think most people think — that he was dying, and that he was dying quickly.I believed the only real option was the Whipple surgery, and that if you weren’t a candidate for it, you were essentially out of options. That’s also what we were led to believe early on by our local care team. At the time, that felt like the full picture. It was not.

What we learned over the next few weeks completely changed how we understood pancreatic cancer and what treatment could look like. There were more options than we had been told, but they weren’t always explained upfront, and some of them depended on information we didn’t even know to ask for yet.

This page is not medical advice. It’s what we learned while trying to understand what options actually existed — and what questions needed to be asked to find them.

Where clinical trials fit

Clinical trials are not just a “last resort.” NCI notes that, because pancreatic cancer is so complex, many experts believe clinical trials are important for patients across disease stages. PanCAN goes further and strongly recommends that patients consider trials at diagnosis and at every treatment decision point.  

Clinical trials may involve:

  • a brand-new drug,

  • a new combination added to standard treatment,

  • a biomarker-matched therapy,

  • a vaccine or immunotherapy approach,

  • or a study testing a better sequencing of existing treatments.  

It is also important to understand that joining a trial does not automatically mean you are receiving “nothing” or being treated like a lab rat. By the time most pancreatic cancer patients are offered a trial, earlier research has already happened, and many cancer trials compare standard treatment against standard treatment plus something new, or compare different active strategies. Placebo-only designs are uncommon when an effective standard treatment already exists. This is consistent with how FDA tissue-agnostic and biomarker-driven approvals have developed from prior trial data over time.  

Let’s Work Together